Sugi Predict

Sugi Predict / Targets / BCDIN3D

BCDIN3D

RNA 5'-monophosphate methyltransferase · Q7Z5W3 · BCDIN3D on Sugi Atlas →

5,209 patent compounds predicted against BCDIN3D, 2,015 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL3446320 SCHEMBL3446320 0.55 18/20
SCHEMBL3445615 SCHEMBL3445615 0.52 14/20
SCHEMBL4158324 SCHEMBL4158324 0.50 14/20
SCHEMBL3751015 SCHEMBL3751015 0.67 13/20
SCHEMBL5491903 SCHEMBL5491903 0.43 13/20
SCHEMBL3755109 SCHEMBL3755109 0.71 12/20
SCHEMBL13650814 SCHEMBL13650814 0.53 12/20
SCHEMBL3445582 SCHEMBL3445582 0.50 12/20
SCHEMBL10156865 SCHEMBL10156865 0.50 11/20
SCHEMBL3172745 SCHEMBL3172745 0.46 11/20
SCHEMBL3172427 SCHEMBL3172427 0.46 11/20
SCHEMBL3446050 SCHEMBL3446050 0.45 11/20
SCHEMBL3170558 SCHEMBL3170558 0.44 11/20
SCHEMBL13942963 SCHEMBL13942963 0.64 10/20
SCHEMBL4211258 SCHEMBL4211258 0.43 10/20
SCHEMBL3444800 SCHEMBL3444800 0.41 10/20
SCHEMBL13942958 SCHEMBL13942958 0.69 9/20
SCHEMBL13942956 SCHEMBL13942956 0.61 9/20
SCHEMBL3182731 SCHEMBL3182731 0.52 9/20
SCHEMBL13828357 SCHEMBL13828357 0.49 9/20

Clinical trials — most relevant to BCDIN3D by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML) PHASE2/PHASE3COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1 PHASE2COMPLETED
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor PHASE1/PHASE2NOT_YET_RECRUITING
A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) PHASE2COMPLETED
Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE1COMPLETED
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma PHASE1RECRUITING
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors PHASE1COMPLETED
Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer PHASE1COMPLETED
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors PHASE1RECRUITING
Effect of DNMT SNPs on DNA Methylation in Primary ITP nanUNKNOWN
The Molecular Pathogenesis Study of Cataract nanUNKNOWN
Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study nanCOMPLETED
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Prognosis of METTL-14 in Endometrial Carcinoma nanNOT_YET_RECRUITING
Using the Epitranscriptome to Diagnose and Treat Gliomas nanRECRUITING
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Expression of TET1 Gene in Acute Leukaemia nanUNKNOWN
Impact Of Choline in Patients With NAFLD nanUNKNOWN
Epigenetics, DNA Methylation Patterns and Periodontal Disease nanCOMPLETED
The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer nanNOT_YET_RECRUITING
Epitranscriptomic Blood Biomarkers for Coronary Artery Disease - A Prospective Cohort Study (IHD-EPITRAN) nanUNKNOWN
Stress and Treatment Response in Puerto Rican Children With Asthma nanCOMPLETED
A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
BAFF Levels and Lupus Nephritis (LN) nanWITHDRAWN
Methylation of DNA in Children and Adolescents With Type 1 Diabetes Mellitus (METHYLDIAB) nanCOMPLETED
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a BCDIN3D binder may also engage these)

ProteinNameSimilarity
Q5RFI3 — 1.000 Q5RFI3 →
Q29S19 — 1.000 Q29S19 →
Q91YP1 — 0.998 Q91YP1 →
D4ABH7 — 0.998 D4ABH7 →
A8E7D2 — 0.989 A8E7D2 →
Q7T0L7 — 0.979 Q7T0L7 →
Q8BMK1 — 0.979 Q8BMK1 →
Q8CAE2 — 0.977 Q8CAE2 →
Q3UY23 — 0.976 Q3UY23 →
Q32PY6 — 0.976 Q32PY6 →
B5DE73 — 0.976 B5DE73 →
Q80Y20 — 0.976 Q80Y20 →
Q96IZ6 — 0.975 Q96IZ6 →
Q5T8I9 — 0.975 Q5T8I9 →
Q6DCD7 — 0.975 Q6DCD7 →
A0JPF9 — 0.974 A0JPF9 →
Q9NVH0 — 0.974 Q9NVH0 →
E1BVR9 — 0.974 E1BVR9 →
Q95K79 — 0.974 Q95K79 →
Q5T7W7 — 0.974 Q5T7W7 →
Q5RL51 — 0.973 Q5RL51 →
Q9BRP7 — 0.973 Q9BRP7 →
Q3U2U7 — 0.973 Q3U2U7 →
Q4R3W5 — 0.973 Q4R3W5 →
Q96BT7 — 0.973 Q96BT7 →
Q2TBP8 — 0.972 Q2TBP8 →
Q5HZW3 — 0.972 Q5HZW3 →
P57075 — 0.972 P57075 →
Q3UZW7 — 0.972 Q3UZW7 →
Q9CXF7 — 0.972 Q9CXF7 →